CoreAge Rx vs Velvet Rx

The verdict

CoreAge Rx edges out Velvet Rx on the Editors' Rating, 94 to 41 (A vs C). Mothers who want to know the real monthly cost before the free trial talks them into it — one flat price on semaglutide or tirzepatide, everywhere in the country, with no lock-in.

Velvet Rx is still a genuine option — velvet Rx is a study in how much a family can actually plan from what a provider publishes. On the credit side, three prices sit on its homepage before any intake, and they are competitive: injectable semaglutide as low as $139 a month, injectable tirzepatide as low as $179, and an oral GLP-1 as low as $189 — the oral option being genuinely uncommon on this page. On the debit side, all three carry 'as low as' and none is ever resolved. No dose ladder, no plan length, no billing cadence, and no pricing page: /pricing and /weight-loss both 404, leaving the homepage as the only page on the site that quotes a figure. For budgeting that is the difference between a price and an opening bid, because the providers here that do publish a ladder routinely double between a starting and a maintenance dose. The rest of the disclosure is similarly thin: no compounding pharmacy named, no clinician named, no state coverage stated, and a cancellation FAQ that asks 'How do cancellations and refunds work?' and replies 'our care team will guide you with personalized support based on your health profile and treatment plan' — a sentence that carries no information. Its operator is Rocket Health Inc., and FDA's warning-letter index is clean for both the brand and that entity, screened with a positive control in the same pass. Weigh the six factors below against your own priorities.